DR. DAKSHA C VYAS M.D.
Prescription History 1922190859
Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology in Merrillville, IN


Quality Rating: 74.63 out of 100 score

NPI Status: Active since September 28, 2006

Contact Information

200 E. 89TH AVE.
SUITE 3 - B
MERRILLVILLE, IN
ZIP 46410
Phone: (219) 769-7861
Fax: (219) 769-6281

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. DAKSHA C VYAS M.D., an active Neurology with Special Qualifications in Child Neurology specialist practicing in Merrillville, IN. Our medical registry currently tracks 70 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 4,368 documented patient claims. Among these therapy options, the most frequently utilized medication is Gabapentin, which accounts for 483 claims alone.


Acetaminophen-Codeine

Generic Formulation: Acetaminophen With CodeineSpecialty: Neurology
Provider Metrics Summary
Total Claims 79
30-Day Fills 79.0
Days Supply 1,492
IN State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills26.0
Peer Average Days Supply411
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 216.0% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $973.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.33

State Avg Cost Per Claim

$15.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. This combination medication is used to help relieve mild to moderate pain. It contains an opioid pain reliever (codeine) and a non-opioid pain reliever (acetaminophen). Codeine works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Alprazolam

Generic Formulation: AlprazolamSpecialty: Neurology
Provider Metrics Summary
Total Claims 79
30-Day Fills 79.2
Days Supply 1,839
IN State Average Benchmarks
Peer Average Claims72.0
Peer Average 30-Day Fills78.7
Peer Average Days Supply2,163
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $385.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.87

State Avg Cost Per Claim

$8.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)

Therapeutic Applications

Alprazolam is used to treat anxiety and panic disorders. It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).

Amantadine

Generic Formulation: Amantadine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 32
30-Day Fills 36.0
Days Supply 1,047
IN State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills42.6
Peer Average Days Supply1,155
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,361.62 across this reporting matrix range.

Provider Avg Cost Per Claim

$42.55

State Avg Cost Per Claim

$65.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.

Therapeutic Applications

Amantadine is used to treat Parkinson's disease, as well as side effects caused by drugs (such as drug-induced extrapyramidal symptoms), chemicals, and other medical conditions. In these cases, this medication may help to improve your range of motion and ability to exercise. For the treatment of these conditions, amantadine is believed to work by restoring the balance of natural chemicals (neurotransmitters) in the brain. Amantadine is used to prevent or treat a certain type of flu (influenza A). If you have been infected with the flu, this medication may help make your symptoms less severe and shorten the time it will take you to get better. Taking amantadine if you have been or will be exposed to the flu may help to prevent you from getting the flu. This medication is an antiviral that is believed to work by stopping growth of the flu virus. This medication is not a vaccine. To increase the chance that you will not get the flu, it is important to get a flu shot once a year at the beginning of every flu season, if possible. Based on the recommendation from the Centers for Disease Control (CDC) in the US, amantadine should not be used to treat or prevent influenza A because the current influenza A virus in the United States and Canada is resistant to this medication. For more details, talk to your doctor or pharmacist.

Amitriptyline Hcl

Generic Formulation: Amitriptyline HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 67
30-Day Fills 110.0
Days Supply 3,286
IN State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills54.4
Peer Average Days Supply1,607
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 139.3% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,690.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.23

State Avg Cost Per Claim

$22.30

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, help you sleep better, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters such as serotonin) in the brain.

Amlodipine Besylate

Generic Formulation: Amlodipine BesylateSpecialty: Neurology
Provider Metrics Summary
Total Claims 48
30-Day Fills 98.0
Days Supply 2,926
IN State Average Benchmarks
Peer Average Claims154.0
Peer Average 30-Day Fills367.8
Peer Average Days Supply10,836
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 68.8% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $447.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.31

State Avg Cost Per Claim

$6.78

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.

Therapeutic Applications

Amlodipine is used with or without other medications to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Amlodipine belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily. Amlodipine is also used to prevent certain types of chest pain (angina). It may help to increase your ability to exercise and decrease the frequency of angina attacks. It should not be used to treat attacks of chest pain when they occur. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor.

Asa-Butalb-Caffeine-Codeine

Generic Formulation: Codeine/Butalbital/Asa/CaffeinSpecialty: Neurology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 315
IN State Average Benchmarks
Peer Average Claims12.0
Peer Average 30-Day Fills12.7
Peer Average Days Supply274
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $475.17 across this reporting matrix range.

Provider Avg Cost Per Claim

$39.60

State Avg Cost Per Claim

$139.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. This combination medication is used to treat tension headaches. Codeine is an opioid pain reliever that acts on certain centers in the brain to give you pain relief. Aspirin helps to decrease the pain from the headache. Caffeine helps increase the effects of aspirin. Butalbital is a sedative that helps to decrease anxiety and cause sleepiness and relaxation.

Atorvastatin Calcium

Generic Formulation: Atorvastatin CalciumSpecialty: Neurology
Provider Metrics Summary
Total Claims 30
30-Day Fills 72.7
Days Supply 2,120
IN State Average Benchmarks
Peer Average Claims216.0
Peer Average 30-Day Fills521.2
Peer Average Days Supply15,330
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 86.1% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $584.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.48

State Avg Cost Per Claim

$11.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

Therapeutic Applications

Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Baclofen

Generic Formulation: BaclofenSpecialty: Neurology
Provider Metrics Summary
Total Claims 57
30-Day Fills 81.0
Days Supply 2,341
IN State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills58.5
Peer Average Days Supply1,576
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 39.0% more claims than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,055.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.51

State Avg Cost Per Claim

$32.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Benztropine Mesylate

Generic Formulation: Benztropine MesylateSpecialty: Neurology
Provider Metrics Summary
Total Claims 19
30-Day Fills 27.1
Days Supply 726
IN State Average Benchmarks
Peer Average Claims58.0
Peer Average 30-Day Fills66.8
Peer Average Days Supply1,818
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 67.2% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $406.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.41

State Avg Cost Per Claim

$13.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.

Therapeutic Applications

Benztropine is used to treat symptoms of Parkinson's disease or involuntary movements due to the side effects of certain psychiatric drugs (antipsychotics such as chlorpromazine/haloperidol). Benztropine belongs to a class of medication called anticholinergics that work by blocking a certain natural substance (acetylcholine). This helps decrease muscle stiffness, sweating, and the production of saliva, and helps improve walking ability in people with Parkinson's disease. Anticholinergics can stop severe muscle spasms of the back, neck, and eyes that are sometimes caused by psychiatric drugs. It can also decrease other side effects such as muscle stiffness/rigidity (extrapyramidal signs-EPS). It is not helpful in treating movement problems caused by tardive dyskinesia and may worsen them. Benztropine should not be used by children younger than 3 years.

Butalbital-Acetaminophen-Caffe

Generic Formulation: Butalb/Acetaminophen/CaffeineSpecialty: Neurology
Provider Metrics Summary
Total Claims 35
30-Day Fills 37.0
Days Supply 831
IN State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills19.2
Peer Average Days Supply374
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 94.4% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $589.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.85

State Avg Cost Per Claim

$38.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to treat tension headaches. Acetaminophen helps to decrease the pain from the headache. Caffeine helps increase the effects of acetaminophen. Butalbital is a sedative that helps to decrease anxiety and cause sleepiness and relaxation.

Carbidopa-Levodopa

Generic Formulation: Carbidopa/LevodopaSpecialty: Neurology
Provider Metrics Summary
Total Claims 40
30-Day Fills 56.0
Days Supply 1,612
IN State Average Benchmarks
Peer Average Claims62.0
Peer Average 30-Day Fills101.9
Peer Average Days Supply2,772
Conservative Utilization

This provider writes prescriptions for this formulation 35.5% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,229.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.73

State Avg Cost Per Claim

$43.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms (such as shakiness, stiffness, difficulty moving). Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting.

Citalopram Hbr

Generic Formulation: Citalopram HydrobromideSpecialty: Neurology
Provider Metrics Summary
Total Claims 74
30-Day Fills 98.2
Days Supply 2,915
IN State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills90.9
Peer Average Days Supply2,656
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 76.2% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $478.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.47

State Avg Cost Per Claim

$7.98

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A furancarbonitrile that is one of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.

Therapeutic Applications

Citalopram is used to treat depression. It may improve your energy level and feelings of well-being. Citalopram is known as a selective serotonin reuptake inhibitor (SSRI). This medication works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Clobazam

Generic Formulation: ClobazamSpecialty: Neurology
Provider Metrics Summary
Total Claims 18
30-Day Fills 21.0
Days Supply 601
IN State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills36.4
Peer Average Days Supply1,014
Conservative Utilization

This provider writes prescriptions for this formulation 41.9% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,083.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$171.28

State Avg Cost Per Claim

$251.07

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine derivative that is a long-acting GABA-A RECEPTOR agonist. It is used as an antiepileptic in the treatment of SEIZURES, including seizures associated with LENNOX-GASTAUT SYNDROME. It is also used as an anxiolytic, for the short-term treatment of acute ANXIETY.

Therapeutic Applications

This medication is used with other medications to help control seizures. It belongs to a class of medications called benzodiazepines, which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA).

Clonazepam

Generic Formulation: ClonazepamSpecialty: Neurology
Provider Metrics Summary
Total Claims 59
30-Day Fills 59.3
Days Supply 1,664
IN State Average Benchmarks
Peer Average Claims53.0
Peer Average 30-Day Fills58.9
Peer Average Days Supply1,641
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $591.62 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.03

State Avg Cost Per Claim

$9.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.

Therapeutic Applications

Clonazepam is used to prevent and control seizures. This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines.

Clonidine Hcl

Generic Formulation: Clonidine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 360
IN State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills57.3
Peer Average Days Supply1,651
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.6% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $96.43 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.04

State Avg Cost Per Claim

$10.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used alone or with other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Clonidine belongs to a class of drugs (central alpha agonists) that act in the brain to lower blood pressure. It works by relaxing blood vessels so blood can flow more easily.

Clopidogrel

Generic Formulation: Clopidogrel BisulfateSpecialty: Neurology
Provider Metrics Summary
Total Claims 61
30-Day Fills 139.7
Days Supply 4,190
IN State Average Benchmarks
Peer Average Claims74.0
Peer Average 30-Day Fills169.4
Peer Average Days Supply4,956
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $953.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.63

State Avg Cost Per Claim

$15.62

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.

Therapeutic Applications

Clopidogrel is used to prevent heart attacks and strokes in persons with heart disease (recent heart attack), recent stroke, or blood circulation disease (peripheral vascular disease). It is also used with aspirin to treat new/worsening chest pain (new heart attack, unstable angina) and to keep blood vessels open and prevent blood clots after certain procedures (such as cardiac stent). Clopidogrel works by blocking platelets from sticking together and prevents them from forming harmful clots. It is an antiplatelet drug. It helps keep blood flowing smoothly in your body.

Cyclobenzaprine Hcl

Generic Formulation: Cyclobenzaprine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 153
30-Day Fills 163.5
Days Supply 4,338
IN State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills51.4
Peer Average Days Supply1,322
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 282.5% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,487.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.72

State Avg Cost Per Claim

$15.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Cyclobenzaprine is used short-term to treat muscle spasms. It is usually used along with rest and physical therapy. It works by helping to relax the muscles. This medication is not recommended for use in older adults because they may be at greater risk for side effects while using this drug. Ask the doctor or pharmacist for details.

Dalfampridine Er

Generic Formulation: DalfampridineSpecialty: Neurology
Provider Metrics Summary
Total Claims 11
30-Day Fills 21.0
Days Supply 616
IN State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills34.9
Peer Average Days Supply996
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.7% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $16,979.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,543.62

State Avg Cost Per Claim

$652.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

One of the POTASSIUM CHANNEL BLOCKERS with secondary effect on calcium currents which is used mainly as a research tool and to characterize channel subtypes.

Therapeutic Applications

Dalfampridine is used to improve walking in people with multiple sclerosis (MS). It is a potassium channel blocker. It is thought to work by improving nerve conduction.

Dextroamphetamine-Amphetamine

Generic Formulation: Dextroamphetamine/AmphetamineSpecialty: Neurology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 315
IN State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills31.6
Peer Average Days Supply936
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 63.3% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $107.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.75

State Avg Cost Per Claim

$40.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to treat attention deficit hyperactivity disorder - ADHD. It works by changing the amounts of certain natural substances in the brain. Amphetamine/dextroamphetamine belongs to a class of drugs known as stimulants. It can help increase your ability to pay attention, stay focused on an activity, and control behavior problems. It may also help you to organize your tasks and improve listening skills. This drug is also used to treat a certain sleeping disorder (narcolepsy) to help you stay awake during the day. It should not be used to treat tiredness or to hold off sleep in people who do not have a sleep disorder.

Diazepam

Generic Formulation: DiazepamSpecialty: Neurology
Provider Metrics Summary
Total Claims 26
30-Day Fills 26.0
Days Supply 419
IN State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills31.4
Peer Average Days Supply743
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,434.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$55.16

State Avg Cost Per Claim

$7.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.

Therapeutic Applications

This medication is used to treat episodes of increased seizures (such as cluster or breakthrough seizures) in people who are already taking medications to control their seizures. This product is only recommended for short-term treatment of seizure attacks. It is not for ongoing daily use to prevent seizures. Uncontrolled seizures can turn into serious (possibly fatal) seizures that do not stop (status epilepticus). This medication is not recommended for children younger than 6 months of age because of the risk of serious side effects. Diazepam works by calming the brain and nerves. It belongs to a class of drugs known as benzodiazepines.

Diclofenac Sodium

Generic Formulation: Diclofenac SodiumSpecialty: Neurology
Provider Metrics Summary
Total Claims 61
30-Day Fills 68.3
Days Supply 1,581
IN State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills53.9
Peer Average Days Supply1,348
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 52.5% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,406.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.06

State Avg Cost Per Claim

$32.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Therapeutic Applications

See also Warning section. This medication is used to relieve joint pain from arthritis. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain.

Dimethyl Fumarate

Generic Formulation: Dimethyl FumarateSpecialty: Neurology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 390
IN State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills23.5
Peer Average Days Supply691
Conservative Utilization

This provider writes prescriptions for this formulation 38.1% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,727.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$517.54

State Avg Cost Per Claim

$2,371.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS.

Therapeutic Applications

Dimethyl fumarate is used to treat multiple sclerosis (MS). It is not a cure for MS. It helps decrease the number of episodes of worsening MS.

Divalproex Sodium

Generic Formulation: Divalproex SodiumSpecialty: Neurology
Provider Metrics Summary
Total Claims 42
30-Day Fills 68.4
Days Supply 2,031
IN State Average Benchmarks
Peer Average Claims55.0
Peer Average 30-Day Fills62.6
Peer Average Days Supply1,543
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,546.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$60.64

State Avg Cost Per Claim

$47.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.

Therapeutic Applications

This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Donepezil Hcl

Generic Formulation: Donepezil HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 175
30-Day Fills 325.1
Days Supply 9,645
IN State Average Benchmarks
Peer Average Claims68.0
Peer Average 30-Day Fills104.3
Peer Average Days Supply2,798
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 157.4% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,467.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.10

State Avg Cost Per Claim

$15.00

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain.

Duloxetine Hcl

Generic Formulation: Duloxetine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 287
30-Day Fills 364.0
Days Supply 10,572
IN State Average Benchmarks
Peer Average Claims59.0
Peer Average 30-Day Fills114.0
Peer Average Days Supply3,313
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 386.4% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,356.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.63

State Avg Cost Per Claim

$41.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.

Therapeutic Applications

Duloxetine is used to treat depression and anxiety. In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Emgality Pen

Generic Formulation: Galcanezumab-GnlmSpecialty: Neurology
Provider Metrics Summary
Total Claims 29
30-Day Fills 29.0
Days Supply 850
IN State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills35.5
Peer Average Days Supply1,043
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21,224.87 across this reporting matrix range.

Provider Avg Cost Per Claim

$731.89

State Avg Cost Per Claim

$862.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to help prevent migraine. It is also used to treat a certain type of headache (episodic cluster headache). Galcanezumab belongs to a class of drugs known as monoclonal antibodies. This medication may work by changing the amounts of certain natural substances in the brain. Using this medication can help improve your ability to concentrate and do your usual tasks.

Escitalopram Oxalate

Generic Formulation: Escitalopram OxalateSpecialty: Neurology
Provider Metrics Summary
Total Claims 18
30-Day Fills 28.0
Days Supply 840
IN State Average Benchmarks
Peer Average Claims61.0
Peer Average 30-Day Fills118.9
Peer Average Days Supply3,412
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 70.5% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $234.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.02

State Avg Cost Per Claim

$14.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder.

Therapeutic Applications

Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI). It may improve your energy level and feelings of well-being and decrease nervousness.

Fluticasone Propionate

Generic Formulation: Fluticasone PropionateSpecialty: Neurology
Provider Metrics Summary
Total Claims 107
30-Day Fills 177.0
Days Supply 5,310
IN State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills85.8
Peer Average Days Supply2,564
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 127.7% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,462.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.67

State Avg Cost Per Claim

$19.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.

Therapeutic Applications

Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

Gabapentin

Generic Formulation: GabapentinSpecialty: Neurology
Provider Metrics Summary
Total Claims 483
30-Day Fills 569.6
Days Supply 16,786
IN State Average Benchmarks
Peer Average Claims107.0
Peer Average 30-Day Fills170.0
Peer Average Days Supply4,888
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 351.4% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,561.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.73

State Avg Cost Per Claim

$20.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Glatiramer Acetate

Generic Formulation: Glatiramer AcetateSpecialty: Neurology
Provider Metrics Summary
Total Claims 20
30-Day Fills 20.0
Days Supply 560
IN State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills22.5
Peer Average Days Supply581
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $76,082.17 across this reporting matrix range.

Provider Avg Cost Per Claim

$3,804.11

State Avg Cost Per Claim

$3,719.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS.

Therapeutic Applications

This medication is used to treat multiple sclerosis (MS). It is a protein that is thought to work by preventing your immune system from attacking the nerves in your brain and spinal cord. This effect can decrease the number of periods of disease worsening (relapses) and prevent or delay disability. It is not a cure for MS.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Neurology
Provider Metrics Summary
Total Claims 67
30-Day Fills 67.0
Days Supply 1,668
IN State Average Benchmarks
Peer Average Claims100.0
Peer Average 30-Day Fills100.4
Peer Average Days Supply2,051
Conservative Utilization

This provider writes prescriptions for this formulation 33.0% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $639.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.55

State Avg Cost Per Claim

$20.47

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Ibuprofen

Generic Formulation: IbuprofenSpecialty: Neurology
Provider Metrics Summary
Total Claims 16
30-Day Fills 18.3
Days Supply 330
IN State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills34.7
Peer Average Days Supply723
Conservative Utilization

This provider writes prescriptions for this formulation 44.8% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $148.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.27

State Avg Cost Per Claim

$10.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties

Therapeutic Applications

Ibuprofen is used to help relieve mild to moderate pain. When used with an opioid (such as morphine), it may be used to relieve moderate to severe pain. It is also used to reduce fever. Ibuprofen is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever.

Lacosamide

Generic Formulation: LacosamideSpecialty: Neurology
Provider Metrics Summary
Total Claims 152
30-Day Fills 165.9
Days Supply 4,966
IN State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills40.6
Peer Average Days Supply1,073
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 360.6% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $37,180.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$244.61

State Avg Cost Per Claim

$282.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An acetamide derivative that acts as a blocker of VOLTAGE-GATED SODIUM CHANNELS. It is used as an anticonvulsant, for adjunctive or monotherapy, in the treatment of PARTIAL SEIZURES.

Therapeutic Applications

Lacosamide is used to prevent and control seizures. It is an anticonvulsant or antiepileptic drug. It works by reducing the spread of seizure activity in the brain.

Lamotrigine

Generic Formulation: LamotrigineSpecialty: Neurology
Provider Metrics Summary
Total Claims 59
30-Day Fills 91.4
Days Supply 2,529
IN State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills78.3
Peer Average Days Supply2,237
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,340.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.72

State Avg Cost Per Claim

$16.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.

Therapeutic Applications

Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

Levetiracetam

Generic Formulation: LevetiracetamSpecialty: Neurology
Provider Metrics Summary
Total Claims 308
30-Day Fills 540.5
Days Supply 15,997
IN State Average Benchmarks
Peer Average Claims58.0
Peer Average 30-Day Fills89.8
Peer Average Days Supply2,444
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 431.0% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,727.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$44.57

State Avg Cost Per Claim

$39.60

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.

Therapeutic Applications

Levetiracetam is used to treat seizures (epilepsy). It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have.

Levothyroxine Sodium

Generic Formulation: Levothyroxine SodiumSpecialty: Neurology
Provider Metrics Summary
Total Claims 36
30-Day Fills 77.3
Days Supply 2,320
IN State Average Benchmarks
Peer Average Claims164.0
Peer Average 30-Day Fills367.7
Peer Average Days Supply10,667
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 78.0% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $535.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.88

State Avg Cost Per Claim

$16.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Lidocaine

Generic Formulation: LidocaineSpecialty: Neurology
Provider Metrics Summary
Total Claims 43
30-Day Fills 45.0
Days Supply 1,195
IN State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills29.2
Peer Average Days Supply789
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 79.2% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,218.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$144.61

State Avg Cost Per Claim

$149.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.

Therapeutic Applications

This product is used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). It may also be used to help relieve nerve pain after shingles (infection with herpes zoster virus). Lidocaine belongs to a class of drugs known as local anesthetics. It works by causing a temporary loss of feeling in the area where you apply the patch.

Lorazepam

Generic Formulation: LorazepamSpecialty: Neurology
Provider Metrics Summary
Total Claims 23
30-Day Fills 24.3
Days Supply 700
IN State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills50.1
Peer Average Days Supply1,258
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $631.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$27.48

State Avg Cost Per Claim

$8.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Therapeutic Applications

This medication is used to treat serious seizures that do not stop (status epilepticus). It is also used before surgeries or procedures to cause drowsiness, decrease anxiety, and cause forgetfulness about the procedure or surgery. Lorazepam belongs to a class of medications called benzodiazepines, which produce a calming effect on the brain and nerves (central nervous system). It is thought to work by increasing the effect of a certain natural chemical (GABA) in the brain.

Meclizine Hcl

Generic Formulation: Meclizine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 55
30-Day Fills 55.0
Days Supply 1,187
IN State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills28.9
Peer Average Days Supply653
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 139.1% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $515.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.37

State Avg Cost Per Claim

$12.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Meclizine is an antihistamine that is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It may also be used to reduce dizziness and loss of balance (vertigo) caused by inner ear problems.

Memantine Hcl

Generic Formulation: Memantine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 35
30-Day Fills 83.0
Days Supply 2,488
IN State Average Benchmarks
Peer Average Claims62.0
Peer Average 30-Day Fills88.0
Peer Average Days Supply2,257
Conservative Utilization

This provider writes prescriptions for this formulation 43.5% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,335.92 across this reporting matrix range.

Provider Avg Cost Per Claim

$38.17

State Avg Cost Per Claim

$48.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

Memantine Hcl Er

Generic Formulation: Memantine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 42
30-Day Fills 58.1
Days Supply 1,584
IN State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills40.2
Peer Average Days Supply1,063
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 40.0% more claims than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,278.91 across this reporting matrix range.

Provider Avg Cost Per Claim

$125.69

State Avg Cost Per Claim

$142.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

Metoprolol Tartrate

Generic Formulation: Metoprolol TartrateSpecialty: Neurology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 330
IN State Average Benchmarks
Peer Average Claims80.0
Peer Average 30-Day Fills176.9
Peer Average Days Supply5,131
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 86.3% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $64.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.82

State Avg Cost Per Claim

$7.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.

Therapeutic Applications

Metoprolol is used with or without other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication is also used to treat chest pain (angina) and to improve survival after a heart attack. Metoprolol belongs to a class of drugs known as beta blockers. It works by blocking the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels. This effect lowers the heart rate, blood pressure, and strain on the heart.

Mirtazapine

Generic Formulation: MirtazapineSpecialty: Neurology
Provider Metrics Summary
Total Claims 40
30-Day Fills 46.0
Days Supply 1,292
IN State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills69.5
Peer Average Days Supply1,916
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $422.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.56

State Avg Cost Per Claim

$25.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Therapeutic Applications

Mirtazapine is used to treat depression. It improves mood and feelings of well-being. Mirtazapine is an antidepressant that works by restoring the balance of natural chemicals (neurotransmitters) in the brain.

Modafinil

Generic Formulation: ModafinilSpecialty: Neurology
Provider Metrics Summary
Total Claims 17
30-Day Fills 17.0
Days Supply 510
IN State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills28.5
Peer Average Days Supply830
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,878.92 across this reporting matrix range.

Provider Avg Cost Per Claim

$404.64

State Avg Cost Per Claim

$192.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.

Therapeutic Applications

Modafinil reduces extreme sleepiness due to narcolepsy and other sleep disorders, such as periods of stopped breathing during sleep (obstructive sleep apnea). It is also used to help you stay awake during work hours if you have a work schedule that keeps you from having a normal sleep routine (shift work sleep disorder). This medication does not cure these sleep disorders and may not get rid of all your sleepiness. Modafinil does not take the place of getting enough sleep. It should not be used to treat tiredness or hold off sleep in people who do not have a sleep disorder. It is not known how modafinil works to keep you awake. It is thought to work by affecting certain substances in the brain that control the sleep/wake cycle.

Montelukast Sodium

Generic Formulation: Montelukast SodiumSpecialty: Neurology
Provider Metrics Summary
Total Claims 16
30-Day Fills 32.3
Days Supply 970
IN State Average Benchmarks
Peer Average Claims63.0
Peer Average 30-Day Fills144.2
Peer Average Days Supply4,265
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 74.6% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $327.63 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.48

State Avg Cost Per Claim

$19.33

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways.

Naproxen

Generic Formulation: NaproxenSpecialty: Neurology
Provider Metrics Summary
Total Claims 58
30-Day Fills 60.5
Days Supply 1,478
IN State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills33.8
Peer Average Days Supply914
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 152.2% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $363.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.26

State Avg Cost Per Claim

$16.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.

Therapeutic Applications

Naproxen is used to relieve mild to moderate pain from various conditions. It also reduces pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This form of naproxen is absorbed slowly and should not be used for pain that needs quick relief (such as during a gout attack). Ask your doctor or pharmacist about using a different form of this drug or other medications for quick relief of pain.

Nurtec Odt

Generic Formulation: Rimegepant SulfateSpecialty: Neurology
Provider Metrics Summary
Total Claims 40
30-Day Fills 40.0
Days Supply 1,166
IN State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills27.4
Peer Average Days Supply658
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 53.8% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $55,941.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,398.54

State Avg Cost Per Claim

$1,286.47

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to prevent or treat migraine. Rimegepant may work by changing the amount of a certain natural substance in the brain. It helps to relieve headache, pain, and other migraine symptoms (such as nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications.

Omeprazole

Generic Formulation: OmeprazoleSpecialty: Neurology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 390
IN State Average Benchmarks
Peer Average Claims109.0
Peer Average 30-Day Fills243.5
Peer Average Days Supply7,132
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 88.1% less volume than the regional standard for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $192.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.81

State Avg Cost Per Claim

$14.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Therapeutic Applications

Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.

Ondansetron Odt

Generic Formulation: OndansetronSpecialty: Neurology
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.3
Days Supply 250
IN State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills25.7
Peer Average Days Supply287
Conservative Utilization

This provider writes prescriptions for this formulation 44.0% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $338.48 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.18

State Avg Cost Per Claim

$23.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Therapeutic Applications

This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting.

Oxcarbazepine

Generic Formulation: OxcarbazepineSpecialty: Neurology
Provider Metrics Summary
Total Claims 51
30-Day Fills 89.2
Days Supply 2,676
IN State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills49.3
Peer Average Days Supply1,373
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 41.7% more claims than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,977.12 across this reporting matrix range.

Provider Avg Cost Per Claim

$136.81

State Avg Cost Per Claim

$69.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A carbamazepine derivative that acts as a voltage-gated sodium channel blocker. It is used for the treatment of PARTIAL SEIZURES with or without secondary generalization. It is also an inducer of CYTOCHROME P-450 CYP3A4.

Therapeutic Applications

Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).

Phenobarbital

Generic Formulation: PhenobarbitalSpecialty: Neurology
Provider Metrics Summary
Total Claims 46
30-Day Fills 46.5
Days Supply 1,254
IN State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills27.0
Peer Average Days Supply709
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 109.1% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,606.73 across this reporting matrix range.

Provider Avg Cost Per Claim

$100.15

State Avg Cost Per Claim

$38.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.

Therapeutic Applications

This medication is used alone or with other medications to control seizures. Controlling and reducing seizures lets you do more of your normal daily activities, reduces your risk of harm when you lose consciousness, and lessens your risk for a possibly life-threatening condition of frequent, repeated seizures. Phenobarbital belongs to a class of drugs known as barbiturate anticonvulsants/hypnotics. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure. This medication is also used for a short time (usually no more than 2 weeks) to help calm you or help you sleep during periods of anxiety. It works by affecting certain parts of the brain to cause calming.

Phenytoin Sodium Extended

Generic Formulation: Phenytoin Sodium ExtendedSpecialty: Neurology
Provider Metrics Summary
Total Claims 12
30-Day Fills 36.0
Days Supply 1,080
IN State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills35.3
Peer Average Days Supply946
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $897.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$74.76

State Avg Cost Per Claim

$39.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Phenytoin is used to prevent and control seizures (also called an anticonvulsant or antiepileptic drug). It works by reducing the spread of seizure activity in the brain.

Pramipexole Dihydrochloride

Generic Formulation: Pramipexole Di-HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 17
30-Day Fills 23.9
Days Supply 676
IN State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills54.1
Peer Average Days Supply1,570
Conservative Utilization

This provider writes prescriptions for this formulation 37.0% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $439.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.86

State Avg Cost Per Claim

$19.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Pramipexole is used alone or with other medications to treat Parkinson's disease. It can improve your ability to move and can decrease shakiness (tremor), stiffness, slowed movement, and unsteadiness. It may also decrease the number of episodes of not being able to move (on-off syndrome). Pramipexole is a dopamine agonist that works by helping to restore the balance of a certain natural substance (dopamine) in the brain.

Prednisone

Generic Formulation: PrednisoneSpecialty: Neurology
Provider Metrics Summary
Total Claims 35
30-Day Fills 35.0
Days Supply 936
IN State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills56.5
Peer Average Days Supply977
Conservative Utilization

This provider writes prescriptions for this formulation 25.5% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $99.63 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.85

State Avg Cost Per Claim

$5.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Therapeutic Applications

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Pregabalin

Generic Formulation: PregabalinSpecialty: Neurology
Provider Metrics Summary
Total Claims 182
30-Day Fills 185.0
Days Supply 5,505
IN State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills59.5
Peer Average Days Supply1,709
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 295.7% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,580.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$74.62

State Avg Cost Per Claim

$47.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.

Therapeutic Applications

This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

Primidone

Generic Formulation: PrimidoneSpecialty: Neurology
Provider Metrics Summary
Total Claims 33
30-Day Fills 67.7
Days Supply 2,030
IN State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills60.3
Peer Average Days Supply1,717
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $887.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.91

State Avg Cost Per Claim

$30.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A barbiturate derivative that acts as a GABA modulator and anti-epileptic agent. It is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite.

Therapeutic Applications

This medication is used alone or with other medications to control seizures. Controlling and reducing seizures lets you do more of your normal daily activities, reduces your risk of harm when you lose consciousness, and lessens your risk for a possibly life-threatening condition of frequent, repeated seizures. Primidone belongs to a class of drugs known as barbiturate anticonvulsants. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.

Propranolol Hcl

Generic Formulation: Propranolol HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 41
30-Day Fills 77.1
Days Supply 2,298
IN State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills43.9
Peer Average Days Supply1,264
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 70.8% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $607.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.81

State Avg Cost Per Claim

$26.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This formulation of propranolol is used for infants and children to treat a certain benign tumor (proliferating infantile hemangioma). It helps to shrink the tumor. Propranolol belongs to a class of drugs known as beta blockers.

Pyridostigmine Bromide

Generic Formulation: Pyridostigmine BromideSpecialty: Neurology
Provider Metrics Summary
Total Claims 24
30-Day Fills 44.0
Days Supply 1,320
IN State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills40.4
Peer Average Days Supply1,170
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,565.19 across this reporting matrix range.

Provider Avg Cost Per Claim

$106.88

State Avg Cost Per Claim

$120.38

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.

Therapeutic Applications

Pyridostigmine is used to improve muscle strength in patients with a certain muscle disease (myasthenia gravis). It works by preventing the breakdown of a certain natural substance (acetylcholine) in your body. Acetylcholine is needed for normal muscle function.

Pyridostigmine Bromide Er

Generic Formulation: Pyridostigmine BromideSpecialty: Neurology
Provider Metrics Summary
Total Claims 11
30-Day Fills 19.0
Days Supply 570
IN State Average Benchmarks
Peer Average Claims14.0
Peer Average 30-Day Fills22.8
Peer Average Days Supply682
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,210.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$655.46

State Avg Cost Per Claim

$701.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.

Therapeutic Applications

Pyridostigmine is used to improve muscle strength in patients with a certain muscle disease (myasthenia gravis). It works by preventing the breakdown of a certain natural substance (acetylcholine) in your body. Acetylcholine is needed for normal muscle function.

Quetiapine Fumarate

Generic Formulation: Quetiapine FumarateSpecialty: Neurology
Provider Metrics Summary
Total Claims 74
30-Day Fills 99.8
Days Supply 2,971
IN State Average Benchmarks
Peer Average Claims52.0
Peer Average 30-Day Fills71.9
Peer Average Days Supply1,984
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 42.3% more claims than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,485.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.07

State Avg Cost Per Claim

$29.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER.

Therapeutic Applications

This medication is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder, sudden episodes of mania or depression associated with bipolar disorder). Quetiapine is known as an anti-psychotic drug (atypical type). It works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain. This medication can decrease hallucinations and improve your concentration. It helps you to think more clearly and positively about yourself, feel less nervous, and take a more active part in everyday life. It may also improve your mood, sleep, appetite, and energy level. Quetiapine can help prevent severe mood swings or decrease how often mood swings occur.

Risperidone

Generic Formulation: RisperidoneSpecialty: Neurology
Provider Metrics Summary
Total Claims 47
30-Day Fills 66.0
Days Supply 1,946
IN State Average Benchmarks
Peer Average Claims54.0
Peer Average 30-Day Fills64.4
Peer Average Days Supply1,685
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $855.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.21

State Avg Cost Per Claim

$16.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.

Therapeutic Applications

Risperidone is used to treat a certain mental/mood disorder called schizophrenia. This medication can decrease hallucinations, help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Risperidone is an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural substances in the brain.

Rizatriptan

Generic Formulation: Rizatriptan BenzoateSpecialty: Neurology
Provider Metrics Summary
Total Claims 57
30-Day Fills 61.4
Days Supply 1,818
IN State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills23.7
Peer Average Days Supply585
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 171.4% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,937.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$104.16

State Avg Cost Per Claim

$31.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Rizatriptan is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Rizatriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Rizatriptan does not prevent future migraines or lessen how often you get migraine attacks.

Sertraline Hcl

Generic Formulation: Sertraline HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 49
30-Day Fills 63.0
Days Supply 1,833
IN State Average Benchmarks
Peer Average Claims77.0
Peer Average 30-Day Fills140.2
Peer Average Days Supply3,965
Conservative Utilization

This provider writes prescriptions for this formulation 36.4% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $508.45 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.38

State Avg Cost Per Claim

$10.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Sertraline is used to treat depression, panic attacks, obsessive compulsive disorder, post-traumatic stress disorder, social anxiety disorder (social phobia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Sertraline is known as a selective serotonin reuptake inhibitor (SSRI). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Sumatriptan Succinate

Generic Formulation: Sumatriptan SuccinateSpecialty: Neurology
Provider Metrics Summary
Total Claims 35
30-Day Fills 35.0
Days Supply 859
IN State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills28.2
Peer Average Days Supply731
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 45.8% more claims than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $599.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.12

State Avg Cost Per Claim

$32.81

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.

Therapeutic Applications

Sumatriptan is used to treat migraines and cluster headaches. It helps to relieve pain and other symptoms of migraines/headaches including sensitivity to light or sound, nausea, and vomiting. Prompt treatment allows you to get back to your normal routine and may decrease your need for other pain medications. It does not prevent future migraines/headaches or reduce how often you may get a headache. Sumatriptan belongs to a group of drugs called triptans. It affects a certain natural chemical (serotonin) that constricts blood vessels in the brain. It may also block other pain pathways in the brain.

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 122
30-Day Fills 158.5
Days Supply 4,497
IN State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills63.7
Peer Average Days Supply1,719
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 171.1% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,534.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.78

State Avg Cost Per Claim

$18.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Topiramate

Generic Formulation: TopiramateSpecialty: Neurology
Provider Metrics Summary
Total Claims 67
30-Day Fills 119.1
Days Supply 3,559
IN State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills61.9
Peer Average Days Supply1,795
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 86.1% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,587.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.69

State Avg Cost Per Claim

$18.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.

Therapeutic Applications

Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug.

Tramadol Hcl

Generic Formulation: Tramadol HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 115
30-Day Fills 120.0
Days Supply 2,503
IN State Average Benchmarks
Peer Average Claims59.0
Peer Average 30-Day Fills60.1
Peer Average Days Supply1,211
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 94.9% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $540.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.70

State Avg Cost Per Claim

$7.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A narcotic analgesic proposed for severe pain. It may be habituating.

Therapeutic Applications

See also Warning section. This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Trazodone Hcl

Generic Formulation: Trazodone HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 41
30-Day Fills 65.0
Days Supply 1,927
IN State Average Benchmarks
Peer Average Claims68.0
Peer Average 30-Day Fills120.7
Peer Average Days Supply3,487
Conservative Utilization

This provider writes prescriptions for this formulation 39.7% less frequently than the standard regional baseline metric for practitioners inside IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $420.09 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.25

State Avg Cost Per Claim

$13.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat depression. It may help to improve your mood, appetite, and energy level as well as decrease anxiety and insomnia related to depression. Trazodone works by helping to restore the balance of a certain natural chemical (serotonin) in the brain.

Ubrelvy

Generic Formulation: UbrogepantSpecialty: Neurology
Provider Metrics Summary
Total Claims 46
30-Day Fills 46.2
Days Supply 1,324
IN State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills28.2
Peer Average Days Supply683
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 76.9% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $56,159.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,220.86

State Avg Cost Per Claim

$1,261.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat migraine. Ubrogepant may work by changing the amount of a certain natural substance in the brain. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. This medication is not used to prevent future migraines or lessen how often you get migraines.

Venlafaxine Hcl Er

Generic Formulation: Venlafaxine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 60
30-Day Fills 74.0
Days Supply 2,220
IN State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills69.8
Peer Average Days Supply2,047
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 76.5% higher than the standard regional baseline profile for IN. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $852.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.21

State Avg Cost Per Claim

$32.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Venlafaxine is used to treat depression, anxiety, panic attacks, and social anxiety disorder (social phobia). It may improve your mood and energy level and may help restore your interest in daily living. It may also decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. Venlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. DAKSHA C VYAS M.D. provides transparency into local medical care patterns within Merrillville, IN.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neurology with Special Qualifications in Child Neurology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.